Report Outlines the Realities of Asthma Care in the United States and the Policy and Clinical Interventions that May Provide Improvements to Current Asthma Care ...
In February 2024, the FDA put two Phase II studies of zelnecirnon under a clinical hold after a case of liver failure was deemed potentially related to the drug.
The researchers ... Burning Incense Can Pose Health Risks for Those With Allergies and Asthma Oct. 24, 2024 — A new medically challenging case warns that, for those with allergies and asthma ...
Drugmaker Viatris beat Wall Street estimates for third-quarter profit and revenue on Thursday, helped by strong demand for its new generic asthma and ADHD drugs, among others, sending its shares up 2.